Ilisa Bernstein

CEO Blog: Ilisa Bernstein, PharmD, JD, FAPhA

Ilisa Bernstein, PharmD, JD, FAPhA, is Interim CEO at the American Pharmacists Association (APhA). She is responsible for leading the development and implementation of APhA’s strategies related to pharmacy practice and professional affairs, advocacy, and government affairs.

Read more about Ilisa

APhA Changes Executive Leadership

Published on Thursday, June 2, 2022

APhA Changes Executive Leadership

Ilisa Bernstein appointed Interim CEO

APhA Changes Executive Leadership

Ilisa Bernstein appointed Interim CEO


The Board of Trustees of the American Pharmacists Association announced today that Ilisa Bernstein, PharmD, JD, FAPhA, has been named Interim CEO, effective immediately. Bernstein’s appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.

“We have full confidence in Ilisa’s leadership as Interim CEO during the transition period,” said Theresa Tolle, BPharm, FAPhA, APhA President. “She brings a passion for pharmacists and pharmacy and a proven record of success strategically leading people and policies – just what is needed to drive APhA’s leadership for the profession.”

“I am excited to be selected to serve as APhA’s Interim CEO, an organization that I’ve cherished and actively been involved with since my student pharmacist days,” said Bernstein. “I look forward to working tirelessly with the Board, staff, members, and stakeholders to ensure a smooth leadership transition and keep our association laser focused on advancing the needs of pharmacists and the profession.”

Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA. For the past 2 ½ years, Bernstein has served as APhA’s Senior Vice President of Pharmacy Practice and Government Affairs, leading the Association’s advocacy and pharmacy practice efforts.

Prior to coming to APhA, Bernstein spent over 30 years advocating for pharmacy and patients at the U.S. Food and Drug Administration, where she held several senior leadership positions, primarily focusing on drug regulation, compliance, enforcement, and pharmacy affairs. Bernstein was also Senior Associate Director of Worldwide Regulatory Affairs for Pfizer and completed a post-doctoral residency in pharmacy at the National Institutes of Health. She earned her Doctor of Pharmacy from the University of Michigan and her Juris Doctor from American University Washington College of Law.

APhA thanks Knoer for his service to the organization through the challenges faced by the profession, particularly during the pandemic.

With Bernstein at the helm, the APhA Board will take the time that is needed to conduct a thorough nationwide search for our next CEO.

About APhA

APhA is the only organization advancing the entire pharmacy profession. Our expert staff and strong volunteer leadership, including many experienced pharmacists, allow us to deliver vital leadership to help pharmacists, pharmaceutical scientists, student pharmacists, and pharmacy technicians find success and satisfaction in their work and advocate for changes that benefit them, their patients, and their communities. For more information, please visit



Rate this article:
No rating
Comments (0)Number of views (14348)
Please login or register to post comments.